Significant innovations in healthcare often require new ways of thinking to recognize their true value. It is the responsibility of the pharmaceutical industry to help drive change that can match healthcare spending to the most valuable innovations. In this poster, we assesses the challenges facing industry in preparing for innovation by synchronizing long-term investment in the broad policy environment with shorter-term market access strategy ahead of brand launch.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...